Brimonidine (Tartrate)
Brimonidine (Tartrate) is an alpha-2 adrenoceptor stimulant. Brimonidine (Tartrate) is used topically to lower the intra-ocular pressure (IOP) in open angle glaucoma or ocular hypertension in patients for whom beta-blockers are inappropriate or may be given as an adjunct to beta-blocker.
Primary Characteristics
It is of Synthetic origin.
Molecular Weight: 442.2 · Non-proprietary name: Brimonidine (Tartrate) · pH: 6.3.
Pharmacokinetics
None recorded.
Advertisement
Indications
Brimonidine (Tartrate) is primarily indicated in conditions like Ocular hypertension, Open-angle glaucoma.
Contraindications
Brimonidine (Tartrate) is contraindicated in conditions like Hypersensitivity to the drug.
Dosage
Brimonidine (Tartrate)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1 drop | 1 drop | Every 8h | Opthalmic | For open angle galucoma/Occular hypertension |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Brimonidine (Tartrate) is known to cause more or less tolerable side effects which are usually transient. These include Asthenia , Blurred vision, Conjunctival bleeding, Dry mouth, Headache, Hyperemia, Increased tearing, Lid retraction, Lids edema, Mydriasis, Ocular irritation, Taste disturbance.
Warnings / Precautions
Available Brands
Storage Conditions
Drug Classification
- 1.21.4.2 — Beta blockers